P-111 PERSPECTIVE: Tepotinib plus cetuximab in patients with RAS/BRAF wild-type left-sided metastatic colorectal cancer and acquired resistance to anti-EGFR antibody therapy due to MET amplification

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Tabernero, J; Bekaii-Saab, T; Safont Aguilera, M; Cubillo, A; Garcia-Carbonero, R; Limon, L; Rodríguez-Salas, N; Tournigand, C; Borg, C; Raghav, K; Finley, G; Strickler, J; Beier, F; Salim, S; Esser, R; Liu, E; Adrian, S; López-López, C

Published Date

  • July 2021

Published In

Volume / Issue

  • 32 /

Start / End Page

  • S136 - S137

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2021.05.166